Fidelity Investments’s 9 Meters Biopharma NMTR Stock Holding History

Fidelity Investments’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-53	Closed	-$36	–	5653
2023 Q2	$36	Buy	+53	New	+$47	﹤0.01%	5071
2022 Q2	–	Sell	-6	Closed	–	–	5657
2022 Q1	$0	Buy	+6	New	+$82	﹤0.01%	5653
2021 Q3	–	Sell	-84	Closed	-$2K	–	5246
2021 Q2	$2K	Buy	84 +74	+740%	+$1.82K	﹤0.01%	3975
2021 Q1	$0	Buy	+10	New	+$307	﹤0.01%	4687

Other funds holding NMTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SIS

Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return

RCM

Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

RFA

Fidelity Investments's NMTR Position: Q3 2023 in Review

Fidelity Investments sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 53 shares — an estimated $36 sold.

Fidelity Investments first reported a position in NMTR in Q1 2021 and held it in 4 quarters. The position peaked at $2K in Q2 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

Fidelity Investments reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
Fidelity Investments sold 53 9 Meters Biopharma shares in Q3 2023, an estimated $36.
Fidelity Investments first reported a position in 9 Meters Biopharma in Q1 2021 and held it in 4 quarters.
Fidelity Investments's 9 Meters Biopharma position peaked at $2K in Q2 2021.
6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Fidelity Investments's 13F filing for Q3 2023, filed 13 Nov 2023.